Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
2957
-
Total 13F shares, excl. options
-
1.88B
-
Shares change
-
+8.52M
-
Total reported value, excl. options
-
$163B
-
Value change
-
+$724M
-
Put/Call ratio
-
0.75
-
Number of buys
-
1457
-
Number of sells
-
-1202
-
Price
-
$86.12
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q3 2022
3,165 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q3 2022.
Merck & Co., Inc. - Common Stock (MRK) has 2,957 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.88B shares
of 2.53B outstanding shares and own 74.56% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (224M shares), BlackRock Inc. (215M shares), STATE STREET CORP (117M shares), GEODE CAPITAL MANAGEMENT, LLC (48.1M shares), WELLINGTON MANAGEMENT GROUP LLP (40.2M shares), BANK OF AMERICA CORP /DE/ (40M shares), MORGAN STANLEY (37.8M shares), Bank of New York Mellon Corp (31M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (31M shares), and NORTHERN TRUST CORP (29.9M shares).
This table shows the top 2957 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.